Novabay Pharmaceuticals Inc RPE

Cos'è RPE di Novabay Pharmaceuticals Inc?

RPE di Novabay Pharmaceuticals Inc è $214.696k

Qual è la definizione di RPE?

I ricavi per dipendente (RPE) sono entrate divise per il numero di dipendenti di un'organizzazione.

RPE di aziende nel Health Care settore su NYSEMKT rispetto a Novabay Pharmaceuticals Inc

Cosa fa Novabay Pharmaceuticals Inc?

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Aziende con rpe simili a Novabay Pharmaceuticals Inc